The Centers for Medicare & Medicaid Services (CMS) confirms that neither CMS nor the Medicare Administrative Contractors (MACs) have made changes that affect patients’ ability to have blood tests used to monitor for organ transplantation rejection covered when
-
Press release
New Medicaid financing approach gives Tennessee unprecedented flexibility supporting innovative, high-quality, fiscally sustainable, and broadly accessible care.
The Centers for Medicare & Medicaid Services (CMS) today approved an innovative demonstration offering
-
Press release
Today, the Centers for Medicare & Medicaid Services (CMS) issued guidance to state health officials designed to drive the adoption of strategies that address the social determinants of health (SDOH) in Medicaid and the Children’s Health Insurance Program (CHIP) so states can
-
News alert
Today, the Centers for Medicare & Medicaid Services (CMS) issued guidance about newly required Medicaid coverage for treatment of opioid use disorders. Medication-assisted treatment (MAT) is an evidence-based treatment that consists of the administration of medications and
-
News alert
Today, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that, for the first time, is requiring that Part D prescription drug plans support a new electronic prior authorization transaction standard for their Part D e-prescribing programs. This new electronic
-
News alert
Today, the Centers for Medicare & Medicaid Services (CMS) released guidance intended to help states restore regular Medicaid and Children’s Health Insurance Program (CHIP) operations after the coronavirus disease 2019 (COVID-19) public health emergency (PHE) ends. Due to the
-
Press release
The Centers for Medicare & Medicaid Services (CMS) announced today, the approval of both the Oklahoma and Maine section 1115 demonstrations to expand treatment for substance abuse disorder. CMS approved Oklahoma’s new demonstration, titled “Institutions for Mental Diseases